Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
NPJ Precision Oncology
|
January 19, 2026
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study
Yoshiaki Nakamura, Johannes G Reiter, Prashanthi Natarajan, et al.
JAMA Oncology
|
July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
Kozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
Nature Medicine
|
June 8, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial
Hideaki Bando, Jun Watanabe, Yusuke Takahashi, et al.
Nature Medicine
|
September 16, 2024
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2019
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
Emil Christensen, Karin Birkenkamp-Demtröder, Himanshu Sethi, et al.
Cancer Cell
|
May 5, 2023
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, et al.
JAMA Oncology
|
May 10, 2019
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen, et al.
Annals of Surgery
|
August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer
Stacey A Cohen, Vasily N Aushev, George Laliotis, et al.
Nature
|
April 27, 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Nature
|
December 21, 2017
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
NPJ Precision Oncology
|
January 19, 2026
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study
Yoshiaki Nakamura, Johannes G Reiter, Prashanthi Natarajan, et al.
JAMA Oncology
|
July 3, 2026
Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases
Kozo Kataoka, Kazuma Ito, Yoshiaki Nakamura, et al.
Nature Medicine
|
June 8, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial
Hideaki Bando, Jun Watanabe, Yusuke Takahashi, et al.
Nature Medicine
|
September 16, 2024
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2019
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
Emil Christensen, Karin Birkenkamp-Demtröder, Himanshu Sethi, et al.
Cancer Cell
|
May 5, 2023
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, et al.
JAMA Oncology
|
May 10, 2019
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen, et al.
Annals of Surgery
|
August 7, 2025
Real-world Monitoring of ctDNA Reliably Predicts Cancer Recurrence and Treatment Efficacy in Patients with Resected Stages I-III Colon Cancer
Stacey A Cohen, Vasily N Aushev, George Laliotis, et al.
Nature
|
April 27, 2017
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Nature
|
December 21, 2017
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, et al.
Page
of 5